410 filings
Page 4 of 21
CORRESP
gp2wvpz8o8m3m0
20 Nov 23
Correspondence with SEC
12:00am
F-3
r0y4pob
3 Nov 23
Shelf registration (foreign)
4:06pm
6-K
99uyz7xjwos20
31 Oct 23
SciSparc Granted Patent from the Australian Patent Office for its Reduction of Opioids Use in Pain Management Technology
8:15am
6-K
6ma8zj87l
24 Oct 23
SciSparc Granted Patent for its Core Technology From the Australian Patent Office
7:54am
D
a0jcgfd4
19 Oct 23
$5.03 mm in options, sold $5.03 mm, 1 investor
4:06pm
6-K
wpbx7w1ekaqe
18 Oct 23
Report of Foreign Private Issuer
6:54am
6-K
hfjzllw4mpfq
16 Oct 23
Interim Consolidated Financial Statements
5:00pm
6-K
b9njp244za
16 Oct 23
SciSparc Ltd. Announces Closing of $5.026 Million Private Placement
4:01pm
6-K
5t9y7ewd
12 Oct 23
SciSparc Ltd. Announces Pricing of $5.026 Million Private Placement
8:48am
6-K
vlvqtvc3z
3 Oct 23
SciSparc Granted European Patent for its Core Technology
7:35am
6-K
3znqj7 b5a
29 Sep 23
SciSparc Announces Expected Implementation of 1-for-26 Reverse Share Split
7:46am
6-K
sju8lrx
21 Sep 23
SciSparc Announces 1-for-26 Reverse Share Split
6:31am
6-K
f1pr50s 6g2nyh
19 Sep 23
SciSparc Engages Investment Bank to Identify Potential Strategic Transaction Opportunities
6:16pm
6-K
a8e ucbki0s9l
7 Sep 23
SciSparc Announces Initiation of Randomized Phase IIb Clinical Trial of its Proprietary SCI-110 for Tourette Syndrome
4:01pm
6-K
6qi8qorj
18 Aug 23
Report of Foreign Private Issuer
4:01pm
6-K
zsxpriu
14 Aug 23
Supplemental Proxy Statement
5:29pm
6-K
6pp40mzj
14 Aug 23
SciSparc Ltd. Announces Pricing of $1.3 Million Underwritten Public Offering
4:31pm
424B5
4tadsn1 9lc2vmr75
14 Aug 23
Prospectus supplement for primary offering
9:14am
424B3
fz9t9xh1ql2pp5t xi
10 Aug 23
Prospectus supplement
6:32am
6-K
uzbmd
9 Aug 23
SciSparc Ltd. Announces Proposed Underwritten Public Offering of Approximately $1.3 Million
7:30pm